Clinical Trials

    Showing 1 - 1 of 1 Jenny Chang

    Converting HR Breast Cancer Into an Individualized Vaccine

    Status: Open Not Enrolling

    Investigator: Jenny Chang

    Study Coordinator: Milan Sheth

    Phone: 713.790.3311

    Hormone receptor positive breast cancer HRBC is the most common cause of BC-related death. HRBC is characterized by a non-immunogenic microenvironment and consequently, modest responses have been observed with immune checkpoint blockade ICB alone or ... Read more >